Form4insider filings, from the source

Company · CIK 0000874015 · SIC 2834 — Pharmaceutical Preparations · Nasdaq

IONIS PHARMACEUTICALS INC · IONS

Insider activity reported against this company. All insider holders · Files at: AKCA, RGLS. On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted
Open-market activity at this companybuys $1.1M · 1sales $99.1M · 181net −$98.0M
$10k$10k$100k$100k$1M$1M$10M$10MbuyssalesJan 2015Dec 2016Nov 2018Oct 2020Sep 2022Aug 2024Jul 2026
Open-market trades as an insider elsewherebuys $225.0M · 2sales $3.8M · 2net $221.2M
$100k$100k$10M$10M$1B$1BbuyssalesJun 2015Dec 2015Jun 2016Nov 2016May 2017Oct 2017Apr 2018

Reported at this company — common stock

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Apr 6, 2016 MForm 4 →Apr 7, 6:18 pm EDTPatrick R. O'NeilSVP, Legal & General Counsel1,000$10.82$10,82010,124— plan?
Apr 6, 2016 SForm 4 →Apr 7, 6:18 pm EDTStanley T CrookeChairman and CEO, Director11,000$46.13$507,3752,170−83.5% plan?
Apr 6, 2016 MForm 4 →Apr 7, 6:18 pm EDTStanley T CrookeChairman and CEO, Director11,000$10.29$113,1902,670— plan?
Mar 31, 2016 SForm 4 →Apr 1, 6:18 pm EDTStanley T CrookeChairman and CEO, Director11,000$40.74$448,0852,170−83.5% plan?
Mar 31, 2016 MForm 4 →Apr 1, 6:18 pm EDTStanley T CrookeChairman and CEO, Director11,000$10.24$112,6552,670— plan?
Mar 23, 2016 SForm 4 →Mar 24, 7:13 pm EDTPatrick R. O'NeilSVP, Legal & General Counsel1,000$45.40$45,4009,124−9.88% plan?
Mar 23, 2016 MForm 4 →Mar 24, 7:13 pm EDTPatrick R. O'NeilSVP, Legal & General Counsel1,000$10.82$10,82010,124— plan?
Feb 19, 2016 MForm 4 →Feb 22, 4:10 pm ESTSpencer R BerthelsenDirector12,500$5.93$74,12574,343— plan?
Feb 3, 2016 MForm 4 →Feb 4, 11:54 am ESTJoseph LoscalzoDirector938——2,543— plan?
Jan 19, 2016 SForm 4 →Jan 19, 8:27 pm ESTStanley T CrookeChairman and CEO, Director13,401$41.46$555,5982,170−86.1% plan?
Jan 19, 2016 SForm 4 →Jan 19, 8:27 pm ESTElizabeth L HougenSVP, Finance & CFO1,899$41.46$78,7426,331−23.1% plan?
Jan 19, 2016 SForm 4 →Jan 19, 8:12 pm ESTPatrick R. O'NeilSVP, Legal & General Counsel1,871$41.46$77,5749,124−17.0% plan?
Jan 19, 2016 SForm 4 →Jan 19, 8:11 pm ESTB Lynne ParshallCOO & Secretary, Director5,192$41.46$215,25716,290−24.2% plan?
Jan 19, 2016 SForm 4 →Jan 19, 8:09 pm ESTRichard S GearySVP, Development2,162$41.46$89,6348,354−20.6% plan?
Jan 19, 2016 SForm 4 →Jan 19, 8:09 pm ESTBrett P MoniaSVP, Antisense Drug Discovery2,208$41.46$91,5417,693−22.3% plan?
Jan 19, 2016 SForm 4 →Jan 19, 8:08 pm ESTSarah BoyceChief Business Officer872$41.46$36,1511,735−33.4% plan?
Jan 19, 2016 SForm 4 →Jan 19, 8:08 pm ESTC Frank BennettSVP, Antisense Research2,110$41.46$87,47410,590−16.6% plan?
Jan 15, 2016 MForm 4 →Jan 19, 8:27 pm ESTStanley T CrookeChairman and CEO, Director24,661——2,315— plan?
Jan 15, 2016 MForm 4 →Jan 19, 8:27 pm ESTElizabeth L HougenSVP, Finance & CFO4,762——6,881— plan?
Jan 15, 2016 MForm 4 →Jan 19, 8:12 pm ESTPatrick R. O'NeilSVP, Legal & General Counsel4,693——9,646— plan?
Jan 15, 2016 MForm 4 →Jan 19, 8:11 pm ESTB Lynne ParshallCOO & Secretary, Director13,267——18,593— plan?
Jan 15, 2016 MForm 4 →Jan 19, 8:09 pm ESTRichard S GearySVP, Development5,427——8,904— plan?
Jan 15, 2016 MForm 4 →Jan 19, 8:09 pm ESTBrett P MoniaSVP, Antisense Drug Discovery5,543——8,297— plan?
Jan 15, 2016 MForm 4 →Jan 19, 8:08 pm ESTSarah BoyceChief Business Officer2,188——2,607— plan?
Jan 15, 2016 MForm 4 →Jan 19, 8:08 pm ESTC Frank BennettSVP, Antisense Research5,295——11,112— plan?
Jan 5, 2016 SForm 4 →Jan 7, 6:52 pm ESTStanley T CrookeChairman and CEO, Director5,500$62.10$341,5501,297−80.9% plan?
Jan 5, 2016 MForm 4 →Jan 7, 6:52 pm ESTStanley T CrookeChairman and CEO, Director5,500$10.19$56,0601,797— plan?
Jan 4, 2016 SForm 4 →Jan 4, 9:26 pm ESTB Lynne ParshallCOO & Secretary, Director809$61.05$49,3898,215−8.96% plan?
Jan 4, 2016 SForm 4 →Jan 4, 9:25 pm ESTPatrick R. O'NeilSVP, Legal & General Counsel1,000$61.10$61,1006,302−13.7% plan?
Jan 4, 2016 SForm 4 →Jan 4, 9:24 pm ESTBrett P MoniaSVP, Antisense Drug Discovery127$61.00$7,7474,358−2.83% plan?
Jan 4, 2016 SForm 4 →Jan 4, 9:22 pm ESTStanley T CrookeChairman and CEO, Director11,000$61.05$671,5501,297−89.5% plan?
Jan 4, 2016 MForm 4 →Jan 4, 9:22 pm ESTStanley T CrookeChairman and CEO, Director11,000$10.19$112,1202,297— plan?
Jan 1, 2016 JMForm 4 →Jan 4, 9:26 pm ESTB Lynne ParshallCOO & Secretary, Director881$17.39$15,3199,024— plan?
Jan 1, 2016 JMForm 4 →Jan 4, 9:25 pm ESTPatrick R. O'NeilSVP, Legal & General Counsel1,043$9.44$9,8447,150— plan?
Jan 1, 2016 JForm 4 →Jan 4, 9:24 pm ESTBrett P MoniaSVP, Antisense Drug Discovery130$47.71$6,2024,485— plan?
Jan 1, 2016 JForm 4 →Jan 4, 9:23 pm ESTElizabeth L HougenSVP, Finance & CFO41$47.71$1,9563,468— plan?
Jan 1, 2016 JForm 4 →Jan 4, 9:23 pm ESTRichard S GearySVP, Development269$47.71$12,8345,089— plan?
Jan 1, 2016 JForm 4 →Jan 4, 9:21 pm ESTSarah BoyceChief Business Officer419$47.71$19,991419— plan?
Jan 1, 2016 JForm 4 →Jan 4, 9:19 pm ESTC Frank BennettSVP, Antisense Research89$47.71$4,2467,405— plan?
Dec 15, 2015 SForm 4 →Dec 17, 7:23 pm ESTC Frank BennettSVP, Antisense Research7,909$57.41$454,0457,316−51.9% plan?
Dec 15, 2015 MForm 4 →Dec 17, 7:23 pm ESTC Frank BennettSVP, Antisense Research7,909$14.47$114,44311,225— plan?
Dec 1, 2015 SForm 4 →Dec 2, 6:49 pm ESTPatrick R. O'NeilSVP, Legal & General Counsel1,000$61.50$61,5006,259−13.8% plan?
Dec 1, 2015 MForm 4 →Dec 2, 6:49 pm ESTPatrick R. O'NeilSVP, Legal & General Counsel1,000$7.25$7,2507,259— plan?
Nov 11, 2015 SForm 4 →Nov 12, 7:02 pm ESTJoseph Klein IIIDirector6,875$64.18$441,2345,543−55.4% plan?
Nov 11, 2015 MForm 4 →Nov 12, 7:02 pm ESTJoseph Klein IIIDirector6,875$10.95$75,3138,668— plan?
Nov 10, 2015 SForm 4 →Nov 12, 7:03 pm ESTC Frank BennettSVP, Antisense Research5,000$64.00$320,0007,316−40.6% plan?
Nov 10, 2015 MForm 4 →Nov 12, 7:03 pm ESTC Frank BennettSVP, Antisense Research5,000$14.47$72,35012,316— plan?
Nov 6, 2015 SForm 4 →Nov 9, 7:28 pm ESTC Frank BennettSVP, Antisense Research5,000$56.00$280,0007,316−40.6% plan?
Nov 6, 2015 MForm 4 →Nov 9, 7:28 pm ESTC Frank BennettSVP, Antisense Research5,000$14.47$72,35012,316— plan?
Nov 3, 2015 SForm 4 →Nov 4, 7:00 pm ESTPatrick R. O'NeilSVP, Legal & General Counsel1,000$51.95$51,9506,259−13.8% plan?
Nov 3, 2015 MForm 4 →Nov 4, 7:00 pm ESTPatrick R. O'NeilSVP, Legal & General Counsel1,000$7.25$7,2507,259— plan?
Oct 21, 2015 SForm 4 →Oct 23, 7:35 pm EDTStanley T CrookeChairman and CEO, Director44,000$43.85$1,929,3551,297−97.1% plan?
Oct 21, 2015 MForm 4 →Oct 23, 7:35 pm EDTStanley T CrookeChairman and CEO, Director44,000$10.67$469,3101,797— plan?
Oct 1, 2015 SForm 4 →Oct 5, 7:14 pm EDTB Lynne ParshallCOO & Secretary, Director12,436$40.75$506,7478,143−60.4% plan?
Oct 1, 2015 MForm 4 →Oct 5, 7:14 pm EDTB Lynne ParshallCOO & Secretary, Director12,436$12.20$151,72011,579— plan?
Jul 6, 2015 SForm 4 →Jul 8, 5:55 pm EDTB Lynne ParshallCOO & Secretary, Director6,218$57.01$354,4708,143−43.3% plan?
Jul 6, 2015 MForm 4 →Jul 8, 5:55 pm EDTB Lynne ParshallCOO & Secretary, Director6,218$7.92$49,26112,986— plan?
Jul 6, 2015 SForm 4 →Jul 8, 5:54 pm EDTStanley T CrookeChairman and CEO, Director6,175$57.01$352,0181,297−82.6% plan?
Jul 6, 2015 MForm 4 →Jul 8, 5:54 pm EDTStanley T CrookeChairman and CEO, Director6,175$10.88$67,1842,472— plan?
Jul 2, 2015 SForm 4 →Jul 2, 6:05 pm EDTBrett P MoniaSVP, Antisense Drug Discovery198$56.30$11,1474,355−4.35% plan?
Jul 1, 2015 SForm 4 →Jul 2, 6:06 pm EDTB Lynne ParshallCOO & Secretary, Director6,218$57.56$357,9148,143−43.3% plan?
Jul 1, 2015 JMForm 4 →Jul 2, 6:06 pm EDTB Lynne ParshallCOO & Secretary, Director6,289$10.72$67,43314,361— plan?
Jul 1, 2015 JForm 4 →Jul 2, 6:05 pm EDTPatrick R. O'NeilSVP, Legal & General Counsel85$48.59$4,1306,259— plan?
Jul 1, 2015 JForm 4 →Jul 2, 6:05 pm EDTBrett P MoniaSVP, Antisense Drug Discovery127$48.59$6,1704,553— plan?
Jul 1, 2015 JForm 4 →Jul 2, 6:04 pm EDTElizabeth L HougenSVP, Finance & CFO40$48.59$1,9433,427— plan?
Jul 1, 2015 JForm 4 →Jul 2, 6:03 pm EDTRichard S GearySVP, Development265$48.59$12,8754,820— plan?
Jul 1, 2015 SForm 4 →Jul 2, 6:02 pm EDTStanley T CrookeChairman and CEO, Director6,175$57.56$355,4391,297−82.6% plan?
Jul 1, 2015 MForm 4 →Jul 2, 6:02 pm EDTStanley T CrookeChairman and CEO, Director6,175$10.88$67,1842,472— plan?
Jul 1, 2015 JForm 4 →Jul 2, 6:01 pm EDTC Frank BennettSVP, Antisense Research87$48.59$4,2277,316— plan?
Jul 1, 2015 MForm 4 →Jul 2, 6:00 pm EDTJoseph H WenderDirector1,448——31,665— plan?
Jul 1, 2015 MForm 4 →Jul 2, 6:00 pm EDTFrederick T MutoDirector1,448——2,543— plan?
Jul 1, 2015 MForm 4 →Jul 2, 5:59 pm EDTJoseph LoscalzoDirector667——1,605— plan?
Jul 1, 2015 MForm 4 →Jul 2, 5:58 pm EDTJoseph Klein IIIDirector1,448——5,543— plan?
Jul 1, 2015 MForm 4 →Jul 2, 5:57 pm EDTBreaux CastlemanDirector2,074——3,481— plan?
Jul 1, 2015 MForm 4 →Jul 2, 5:57 pm EDTSpencer R BerthelsenDirector1,448——61,843— plan?
Jun 8, 2015 SForm 4 →Jun 10, 6:36 pm EDTBrett P MoniaSVP, Antisense Drug Discovery7,600$66.22$503,2804,426−63.2% plan?
Jun 8, 2015 MForm 4 →Jun 10, 6:36 pm EDTBrett P MoniaSVP, Antisense Drug Discovery7,600$10.29$78,20412,026— plan?
Jun 1, 2015 SForm 4 →Jun 3, 5:29 pm EDTFrederick T MutoDirector10,000$66.91$669,1101,095−90.1% plan?
Jun 1, 2015 MForm 4 →Jun 3, 5:29 pm EDTFrederick T MutoDirector10,000$3.95$39,50011,095— plan?
Apr 17, 2015 MForm 4 →Apr 17, 6:13 pm EDTSpencer R BerthelsenDirector10,000$3.95$39,50060,395— plan?
Apr 7, 2015 SForm 4 →Apr 8, 5:12 pm EDTB Lynne ParshallCOO & Secretary, Director5,565$63.07$350,9908,072−40.8% plan?
Apr 7, 2015 MForm 4 →Apr 8, 5:12 pm EDTB Lynne ParshallCOO & Secretary, Director5,565$14.69$81,75013,637— plan?
Apr 7, 2015 SForm 4 →Apr 8, 5:11 pm EDTStanley T CrookeChairman and CEO, Director22,377$63.07$1,411,3401,297−94.5% plan?
Apr 7, 2015 MForm 4 →Apr 8, 5:11 pm EDTStanley T CrookeChairman and CEO, Director22,377$11.08$248,0193,331— plan?
Apr 1, 2015 SForm 4 →Apr 6, 11:51 am EDTB Lynne ParshallCOO & Secretary, Director5,377$61.93$333,0098,072−40.0% plan?
Apr 1, 2015 MForm 4 →Apr 6, 11:51 am EDTB Lynne ParshallCOO & Secretary, Director5,377$14.69$78,98813,449— plan?
Apr 1, 2015 SForm 4 →Apr 6, 11:50 am EDTStanley T CrookeChairman and CEO, Director21,623$61.93$1,339,1581,297−94.3% plan?
Apr 1, 2015 MForm 4 →Apr 6, 11:50 am EDTStanley T CrookeChairman and CEO, Director21,623$11.08$239,6613,263— plan?
Mar 23, 2015 SForm 4 →Mar 25, 4:23 pm EDTC Frank BennettSVP, Antisense Research15,000$70.61$1,059,1107,229−67.5% plan?
Mar 23, 2015 MForm 4 →Mar 25, 4:23 pm EDTC Frank BennettSVP, Antisense Research15,000$14.47$217,05016,229— plan?
Mar 19, 2015 SForm 4 →Mar 20, 6:58 pm EDTElizabeth L HougenSVP, Finance & CFO10,000$73.33$733,2603,387−74.7% plan?
Mar 19, 2015 MForm 4 →Mar 20, 6:58 pm EDTElizabeth L HougenSVP, Finance & CFO10,000$11.27$112,70013,387— plan?
Mar 19, 2015 SForm 4 →Mar 20, 6:56 pm EDTRichard S GearySVP, Development8,000$75.00$600,0324,555−63.7% plan?
Mar 19, 2015 MForm 4 →Mar 20, 6:56 pm EDTRichard S GearySVP, Development8,000$14.69$117,52012,555— plan?
Mar 19, 2015 SForm 4 →Mar 20, 6:55 pm EDTPatrick R. O'NeilSVP, Legal & General Counsel30,525$74.85$2,284,7576,174−83.2% plan?
Mar 19, 2015 MForm 4 →Mar 20, 6:55 pm EDTPatrick R. O'NeilSVP, Legal & General Counsel30,525$22.62$690,41616,699— plan?
Mar 18, 2015 SForm 4 →Mar 20, 6:57 pm EDTJoseph H WenderDirector12,500$71.41$892,58630,217−29.3% plan?
Mar 18, 2015 MForm 4 →Mar 20, 6:57 pm EDTJoseph H WenderDirector12,500$5.93$74,12536,617— plan?
Mar 5, 2015 MForm 4 →Mar 9, 7:45 pm EDTRichard S GearySVP, Development15,080$8.88$133,97211,555— plan?
Mar 5, 2015 SForm 4 →Mar 9, 7:45 pm EDTRichard S GearySVP, Development18,095$71.15$1,287,3824,555−79.9% plan?

Reported at this company — derivatives (options, RSUs, warrants)

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Dec 15, 2015 MForm 4 →Dec 17, 7:23 pm ESTC Frank BennettSVP, Antisense Research7,909——0—
Dec 1, 2015 MForm 4 →Dec 2, 6:49 pm ESTPatrick R. O'NeilSVP, Legal & General Counsel1,000——2,067—
Nov 11, 2015 MForm 4 →Nov 12, 7:02 pm ESTJoseph Klein IIIDirector6,875——2,812—
Nov 10, 2015 MForm 4 →Nov 12, 7:03 pm ESTC Frank BennettSVP, Antisense Research5,000——7,909—
Nov 9, 2015 GForm 4 →Nov 9, 7:45 pm ESTB Lynne ParshallCOO & Secretary, Director8,000——1,000—
Nov 6, 2015 MForm 4 →Nov 9, 7:28 pm ESTC Frank BennettSVP, Antisense Research5,000——12,909—
Nov 3, 2015 MForm 4 →Nov 4, 7:00 pm ESTPatrick R. O'NeilSVP, Legal & General Counsel1,000——3,067—
Oct 21, 2015 MForm 4 →Oct 23, 7:35 pm EDTStanley T CrookeChairman and CEO, Director44,000——2,000—
Oct 1, 2015 MForm 4 →Oct 5, 7:14 pm EDTB Lynne ParshallCOO & Secretary, Director12,436——29,354—
Jul 6, 2015 MForm 4 →Jul 8, 5:55 pm EDTB Lynne ParshallCOO & Secretary, Director6,218——17,027—
Jul 6, 2015 MForm 4 →Jul 8, 5:54 pm EDTStanley T CrookeChairman and CEO, Director6,175——5,000—
Jul 1, 2015 MForm 4 →Jul 2, 6:06 pm EDTB Lynne ParshallCOO & Secretary, Director6,218——1,375—
Jul 1, 2015 MForm 4 →Jul 2, 6:02 pm EDTStanley T CrookeChairman and CEO, Director6,175——6,175—
Jul 1, 2015 AMForm 4 →Jul 2, 6:00 pm EDTJoseph H WenderDirector20,115——16,000—
Jul 1, 2015 AMForm 4 →Jul 2, 6:00 pm EDTFrederick T MutoDirector20,115——16,000—
Jul 1, 2015 AMForm 4 →Jul 2, 5:59 pm EDTJoseph LoscalzoDirector19,334——16,000—
Jul 1, 2015 AMForm 4 →Jul 2, 5:58 pm EDTJoseph Klein IIIDirector20,115——16,000—
Jul 1, 2015 AMForm 4 →Jul 2, 5:57 pm EDTBreaux CastlemanDirector20,741——16,000—
Jul 1, 2015 AMForm 4 →Jul 2, 5:57 pm EDTSpencer R BerthelsenDirector20,115——16,000—
Jun 8, 2015 MForm 4 →Jun 10, 6:36 pm EDTBrett P MoniaSVP, Antisense Drug Discovery7,600——0—
Jun 1, 2015 MForm 4 →Jun 3, 5:29 pm EDTFrederick T MutoDirector10,000——0—
Apr 17, 2015 MForm 4 →Apr 17, 6:13 pm EDTSpencer R BerthelsenDirector10,000——0—
Apr 7, 2015 MForm 4 →Apr 8, 5:12 pm EDTB Lynne ParshallCOO & Secretary, Director5,565——37,628—
Apr 7, 2015 MForm 4 →Apr 8, 5:11 pm EDTStanley T CrookeChairman and CEO, Director22,377——7,350—
Apr 1, 2015 MForm 4 →Apr 6, 11:51 am EDTB Lynne ParshallCOO & Secretary, Director5,377——43,193—
Apr 1, 2015 MForm 4 →Apr 6, 11:50 am EDTStanley T CrookeChairman and CEO, Director21,623——9,384—
Mar 23, 2015 MForm 4 →Mar 25, 4:23 pm EDTC Frank BennettSVP, Antisense Research15,000——17,909—
Mar 19, 2015 MForm 4 →Mar 20, 6:58 pm EDTElizabeth L HougenSVP, Finance & CFO10,000——10,000—
Mar 19, 2015 MForm 4 →Mar 20, 6:56 pm EDTRichard S GearySVP, Development8,000——17,240—
Mar 19, 2015 MForm 4 →Mar 20, 6:55 pm EDTPatrick R. O'NeilSVP, Legal & General Counsel30,525——31,875—
Mar 18, 2015 MForm 4 →Mar 20, 6:57 pm EDTJoseph H WenderDirector12,500——0—
Mar 5, 2015 MForm 4 →Mar 9, 7:45 pm EDTRichard S GearySVP, Development15,080——7,035—
Mar 5, 2015 MForm 4 →Mar 9, 7:27 pm EDTElizabeth L HougenSVP, Finance & CFO28,094——4,063—
Mar 5, 2015 MForm 4 →Mar 9, 7:27 pm EDTPatrick R. O'NeilSVP, Legal & General Counsel5,800——1,617—
Mar 5, 2015 MForm 4 →Mar 9, 7:26 pm EDTJoseph H WenderDirector12,500——0—
Mar 5, 2015 MForm 4 →Mar 9, 7:25 pm EDTJoseph Klein IIIDirector10,000——5,937—
Feb 12, 2015 MForm 4 →Feb 17, 5:39 pm ESTJoseph H WenderDirector10,000——0—
Feb 3, 2015 MForm 4 →Feb 5, 6:08 pm ESTJoseph LoscalzoDirector938——2,812—
Jan 27, 2015 MForm 4 →Jan 29, 7:03 pm ESTStanley T CrookeChairman and CEO, Director11,000——11,350—
Jan 15, 2015 AMForm 4 →Jan 20, 8:00 pm ESTStanley T CrookeChairman and CEO, Director46,375——1,062—
Jan 15, 2015 AForm 4 →Jan 20, 7:59 pm ESTSarah BoyceChief Business Officer8,750——8,750—
Jan 15, 2015 AMForm 4 →Jan 20, 7:58 pm ESTB Lynne ParshallCOO & Secretary, Director29,824——10,312—
Jan 15, 2015 AMForm 4 →Jan 20, 7:57 pm ESTBrett P MoniaSVP, Antisense Drug Discovery10,095——5,625—
Jan 15, 2015 AMForm 4 →Jan 20, 7:57 pm ESTElizabeth L HougenSVP, Finance & CFO8,901——5,625—
Jan 15, 2015 AMForm 4 →Jan 20, 7:56 pm ESTPatrick R. O'NeilSVP, Legal & General Counsel8,625——5,625—
Jan 15, 2015 AMForm 4 →Jan 20, 7:55 pm ESTC Frank BennettSVP, Antisense Research9,226——5,625—
Jan 15, 2015 AMForm 4 →Jan 20, 7:53 pm ESTRichard S GearySVP, Development9,567——5,625—
Jan 9, 2015 MForm 4 →Jan 13, 6:51 pm ESTStanley T CrookeChairman and CEO, Director11,000——12,350—
Jan 6, 2015 MForm 4 →Jan 8, 7:15 pm ESTStanley T CrookeChairman and CEO, Director22,000——13,350—
Jan 2, 2015 AMForm 4 →Jan 5, 8:04 pm ESTB Lynne ParshallCOO & Secretary, Director143,658——48,570—
Jan 2, 2015 AMForm 4 →Jan 5, 8:03 pm ESTPatrick R. O'NeilSVP, Legal & General Counsel32,957——9,750—
Jan 2, 2015 AMForm 4 →Jan 5, 8:02 pm ESTStanley T CrookeChairman and CEO, Director173,700——8,700—
Jan 2, 2015 AForm 4 →Jan 5, 8:01 pm ESTElizabeth L HougenSVP, Finance & CFO33,112——33,112—
Jan 2, 2015 AForm 4 →Jan 5, 7:59 pm ESTC Frank BennettSVP, Antisense Research31,457——31,457—
Jan 2, 2015 AForm 4 →Jan 5, 7:57 pm ESTRichard S GearySVP, Development33,112——33,112—
Jan 2, 2015 AForm 4 →Jan 5, 7:56 pm ESTBrett P MoniaSVP, Antisense Drug Discovery36,423——36,423—
Jan 1, 2015 AForm 4 →Jan 5, 8:31 pm ESTSarah BoyceChief Business Officer52,500——52,500—

Filed by this entity as an insider elsewhere — common stock

TradeReported (ET)CompanySharesAvg priceTotalOwned afterΔ stakeFlags
Oct 17, 2018 JForm 4 →Oct 18, 8:05 pm EDTAKCEA THERAPEUTICS, INC.AKCA1,671,849——67,383,965— plan?
Aug 3, 2018 JForm 4 →Aug 6, 5:17 pm EDTAKCEA THERAPEUTICS, INC.AKCA1,597,571——65,712,116— plan?
Apr 17, 2018 PForm 4 →Apr 19, 6:48 pm EDTAKCEA THERAPEUTICS, INC.AKCA10,666,666$18.75$199,999,98864,114,545+20.0% plan?
Apr 17, 2018 JForm 4 →Apr 19, 6:48 pm EDTAKCEA THERAPEUTICS, INC.AKCA8,000,000——53,447,879— plan?
Jul 19, 2017 PForm 4 →Jul 21, 4:04 pm EDTAKCEA THERAPEUTICS, INC.AKCA3,125,000$8.00$25,000,00045,447,879+7.38% plan?
Jul 19, 2017 CJForm 4 →Jul 21, 4:04 pm EDTAKCEA THERAPEUTICS, INC.AKCA42,322,879——42,322,879— plan?
Jul 15, 2015 SForm 4 →Jul 17, 6:08 pm EDTRegulus Therapeutics Inc.RGLS343,133$10.60$3,636,0785,173,172−6.22% plan?
Jun 30, 2015 SForm 4 →Jul 2, 4:28 pm EDTRegulus Therapeutics Inc.RGLS13,248$10.79$143,0105,516,305−0.24% plan?
Jun 23, 2015 GForm 4 →Jul 2, 4:28 pm EDTRegulus Therapeutics Inc.RGLS13,248——5,529,553— plan? late

Filed by this entity as an insider elsewhere — derivatives (options, RSUs, warrants)

TradeReported (ET)CompanySharesAvg priceTotalOwned afterΔ stakeFlags
Jul 19, 2017 CForm 4 →Jul 21, 4:04 pm EDTAKCEA THERAPEUTICS, INC.AKCA28,884,540——0—